Navigation Links
Hospital gives first tomosynthesis mammograms in region this week
Date:12/7/2011

There is still a one in eight lifetime risk that a woman will develop breast cancer, and the best tool against the disease remains early detection. Now, Women & infants Hospital of Rhode Island has taken the breast cancer battle to the next level with the installation of the most advanced imaging technology available, called digital breast tomosynthesis.

Women & Infants is the first and only facility in southeastern New England to offer this new technology, which was approved in February 2011 by the federal Food and Drug Administration (FDA). The first woman to receive a digital tomosynthesis test in the region was processed at the hospital yesterday.

Digital breast tomosynthesis captures three-dimensional images of the breast versus the two-dimensional ones available through standard full-field digital mammography. This gives a more comprehensive and clear image for the radiologist to interpret, increases the early detection rate for breast cancer by up to 15%, and decreases the number of false positive findings by about 25%.

"Tomosynthesis gives doctors a clearer view of a woman's breast tissue and significantly helps us screen for and find potential breast cancers," explained Patricia Spencer, MD, chief of the Department of Diagnostic Imaging at Women & Infants.

The new technology is used at the same time the technologist conducts a routine digital mammography, which is still considered the "gold standard" in breast imaging. However, the two-dimensional digital mammography takes an image of the entire breast in one exposure, which means features of the breast can be hidden by overlapping tissue.

Tomosynthesis takes images from multiple angles and uses computer processing to compile them into a three-dimensional picture a radiologist can examine and manipulate. The added detail helps the radiologist pinpoint the size, location and shape of any breast abnormality, and can help distinguish real tumors from harmless abnormalities. Because digital breast tomosynthesis removes the layers of breast structure and tissue, it is particularly beneficial for women with dense breasts.

"The result is fewer calls to patients for further testing and less overall anxiety for women," Dr. Spencer said. Even though in 2010, the U.S. Preventive Services Task Force recommended screening every two years for women ages 50 to 74, the American Cancer Society still recommends annual screening for all women age 40 and older. Women & Infants adheres to the American Cancer Society recommendations, believing the best chance for survival and cure is early detection. This is the hospital's motivation for bringing the advanced technology of digital breast tomosynthesis to the women of Rhode Island and southeastern New England.


'/>"/>
Contact: Susan McDonald
slmcdonald@wihri.org
401-681-2816
Women & Infants Hospital
Source:Eurekalert

Related medicine news :

1. The private sale of drugs in public hospitals
2. Minnesota Department of Health Report: Nearly 6,000 Hospitalizations for COPD in 2007
3. Bariatricfurnishings.com Launches Unique Eco-friendly Seating for Health Care, Hospitality, Assisted Living Centers, and Home Use at Competitive Prices
4. Scott & White Memorial Hospital uses device to revolutionize treatment of traumatic aortic injury
5. Most pandemic plans in Ontario hospitals have not been tested: Queens University study
6. American Heart Association Comment on Hospitalization of President Bill Clinton
7. Allegheny General Hospital Study Demonstrates Safety and Potential Efficacy of Oral Allergy Treatment
8. SHARECOR Partners With Quantros, Inc. to Facilitate Core Measures and Regulatory Reporting in Louisiana Hospitals
9. Kaiser Foundation Health Plan and Hospitals Report Fourth Quarter and Fiscal Year 2009 Financial Results
10. Father Channels His Grief into Advocacy, Promotes Simple Actions to Make Hospitals Safer for Children
11. Catholic Health East and BayCare Health System Pledge $200,000 to Rebuild Hospital in Port-Au-Prince
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact Phyllis ... Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning author ... memory. The book’s publication date is March 16, 2016. A free review copy ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... digital self-scheduling readily available to physicians. The integration will enable Allscripts users ... select appointments via Everseat’s free mobile app. , The partnership gives Everseat substantial ...
(Date:2/10/2016)... CA (PRWEB) , ... February 10, 2016 , ... Workrite ... and most versatile series of monitor mounts ever. , “Our goal was to ... and easy to install system that we have ever created.” said Darren Hulsey, Product ...
(Date:2/10/2016)... ... ... Anxiety of older Americans over steep cost increases of prescription drugs is at ... to The Senior Citizens League (TSCL). Since last fall, TSCL has ... costs. “The implications are chilling, particularly for people with chronic health problems,” says ...
(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. Clevens, MD, ... to welcome a new addition to their growing practice. Beginning this month, Teresa ... nurse practitioner performing cosmetic procedures including injectables, fillers and laser treatments. ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016  The ALS Association, in partnership with ALS Finding ... generate a biomarker to track TDP43 aggregation. The successful team(s) ... $1 million investment. --> ... nerve cells in the brain and the spinal cord. Eventually, ... muscle movement, which often leads to total paralysis and death ...
(Date:2/10/2016)... , Feb. 10, 2016  LexisNexis® Risk ... technology, today announced the launch of LexisNexis ... solution that helps improve and optimize the quality ... of performance using severity-adjusted scores. By measuring provider ... critical solution to deliver better outcomes, improve the ...
(Date:2/10/2016)... CORAL SPRINGS, Florida , February 10, 2016 ... Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS ) and Celldex Therapeutics, ... Medivation, Inc. (NASDAQ: MDVN ), Adamas Pharmaceuticals, Inc. (NASDAQ: ... ). --> Today,s latest Orphan Drug Designations become ... granted by the FDA to novel drugs and biologics which ...
Breaking Medicine Technology: